Genus (GENSF)

PNK: GENSF · Real-Time Price · USD

21.77

0.00 (0.00%)

At close: Apr 25, 2025, 10:08 AM

0.00% (1D)

Bid	21.77
Market Cap	1.43B
Revenue (ttm)	1.01B
Net Income (ttm)	27.8M
EPS (ttm)	-0.08
PE Ratio (ttm)	-272.1
Forward PE	n/a
Analyst	n/a

Ask	28.29
Volume	958
Avg. Volume (20D)	42
Open	21.00
Previous Close	21.77
Day's Range	21.00 - 21.77
52-Week Range	20.51 - 28.01
Beta	0.60

About GENSF

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with va...

[Read more]

Industry Biotechnology

Sector Healthcare

IPO Date Sep 11, 2009

Employees 3,500

Stock Exchange PNK

Ticker Symbol GENSF

Website https://www.genusplc.com

Full Company Profile

News

23 hours ago · proactiveinvestors.co.uk

Genus FDA green light a “hugely significant landmark"

Genus PLC (LSE:GNS) shares jumped 24% on Wednesday after the US Food and Drug Administration approved its gene-edited PRRS-resistant pigs for use in the American food chain, a decision analysts at Pan...

1 day ago · reuters.com

UK's Genus secures FDA approval for PRP gene edit; shares soar

British animal genetics company Genus on Wednesday said the U.S. Food and Drug Administration (FDA) approved its PRP gene edit under its PRRS Resistant Pig ("PRP") programme for use in the U.S. food s...

1 day ago · proactiveinvestors.co.uk

Genus shares leap 22% after FDA clears gene-edited pigs for US food chain

Shares in Genus PLC (LSE:GNS) surged 22% on Wednesday after the US Food and Drug Administration approved the company's gene-edited pigs for use in the American food supply. It marks a major breakthrou...

2 months ago · seekingalpha.com

Genus plc (GENSF) Q2 2025 Earnings Call Transcript

Genus plc (OTCPK:GENSF) Q2 2025 Earnings Conference Call February 27, 2025 3:30 AM ET Company Participants Jorgen Kokke - CEO Alison Henriksen - CFO Conference Call Participants Charles Hall - Peel Hu...